Neuroone Medical Technologies (NMTC) Current Leases (2023 - 2024)
Neuroone Medical Technologies' (NMTC) quarterly Current Leases came in at $65768.0 in Q3 2024, down 49.06% YoY from $129116.0 in Q4 2023, and down 49.06% on a QoQ basis from $129116.0 in Q3 2023.
Neuroone Medical Technologies (NMTC) Current Leases (2023 - 2024) Analysis & Trends
Neuroone Medical Technologies (NMTC) has 2 years of Current Leases data on file, last reported at $65768.0 in Q3 2024.
- Quarterly Current Leases fell 49.06% year-over-year to $65768.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $65768.0 (down 49.06% YoY) and the FY2024 annual result came in at $65768.0, down 49.06% from the prior year.
- Current Leases eased to $65768.0 in Q3 2024, from $129116.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $129116.0 in Q3 2023 to a low of $65768.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 24.10 Mn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 20.70 Mn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | - |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 35.60 Mn |
| 10 | Neuroone Medical Technologies | 19.89 Mn | 17.84 Mn | 1.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 65,768.00 |
| Sep 30, 2023 | 129,116.00 |